Breakthrough ALS Gene Therapy Launches in the Chinese Mainland
Biogen launches Tofersen, a breakthrough gene-targeted drug for ALS in the Chinese mainland, targeting SOD1 mutations and offering new hope.
geneTherapy
Read More
Breakthrough Gene Therapy for Hemophilia B in China
China approves BBM-H901, its first gene therapy for hemophilia B, marking a new era in personalized healthcare.